Patent search ap:("THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK") AND inv:"LIN Page Richard"

1.

发明申请
GENETICALLY MODIFIED T-CELLS AND PI3K/AKT INHIBITORS FOR CANCER TREATMENT 审中-公开

公开(公告)号：WO2019199860A1

公开(公告)日：2019-10-17

申请号：PCT/US2019/026627

申请日：2019-04-09

Applicant: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK

Inventor： LIN, Richard

IPC: A61K31/6615 , A61K31/683 , A61K38/00

Abstract: The present invention relates to the field of cancer biology and immunology. More specifically, the present invention relates to the use of genetically modified immune cells in combination with certain chemotherapeutic agents for the treatment of cancer, wherein the genetically modified immune cells are resistant to said chemotherapeutic agents.

Patent Agency Ranking